BioCurex To Commercialize OncoPet Recaf Test For Cancer Detection In Dogs
February 11, 2010
BioCurex Inc., a biotechnology company developing products based on patented technology in the areas of cancer diagnostics, on Feb. 11 said it has commercialized its OncoPet Recaf test for cancer detection in dogs. The test finds 85 percent of a variety of cancers in dogs, the company said, at the standard 95 percent specificity level… Continue reading...